DEFA14A: Clover Health Investments Corp. Sets Date for 2024 Annual Meeting, Outlines Voting Matters

Clover Health Investments Corp. announces its 2024 Annual Meeting to be held virtually on June 10, 2024, outlining key proposals for stockholder voting including the election of directors, executive compensation, and auditor ratification.

Summary

• Clover Health Investments Corp. will hold its Annual Meeting on June 10, 2024, at 11:00 a.m. Eastern Time, conducted virtually.
• Stockholders are invited to vote on several key proposals.
• These proposals include the election of three directors: Chelsea Clinton, Carladenise Armbrister Edwards, and Vivek Garipalli.
• A non-binding advisory vote will be held to approve the compensation paid to named executive officers for 2023.
• Stockholders will also vote on the ratification of Ernst & Young LLP as the company's independent registered public accounting firm.
• Proxy materials, including the Annual Report and Notice & Proxy Statement, are available online.
• Stockholders can request a free paper or email copy of these materials before May 27, 2024.
• Votes must be cast by June 9, 2024, at 11:59 PM ET.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an annual meeting and voting matters, indicating a neutral to slightly positive sentiment as it reflects standard corporate governance practices.

Positives

• The company is providing multiple avenues for stockholders to access proxy materials and cast their votes, including online access, phone requests, and email requests.
• The virtual format of the Annual Meeting allows for broader participation from stockholders.

Future Outlook

The document outlines the matters to be addressed at the upcoming Annual Meeting, providing a framework for the company's governance and strategic direction as determined by stockholder votes.

Industry Context

This announcement is a standard corporate procedure for publicly traded companies, ensuring stockholders have the opportunity to participate in key decisions regarding the company's governance and operations.

Stakeholder Impact

• Stockholders have the opportunity to influence the company's direction through their votes on key proposals.
• The outcome of the votes will impact the composition of the board of directors and the ratification of the company's auditor.

Next Steps

• Stockholders should review the proxy materials and cast their votes by the June 9, 2024 deadline.
• The company will proceed with the Annual Meeting on June 10, 2024, and implement the outcomes of the stockholder votes.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Voting, Directors, Executive Compensation, Auditor, Clover Health